Publications by authors named "Marta L Capone"

Claim this Profile
R
Reduced Variability to Aspirin Antiplatelet Effect by the Coadministration of Statins in High-Risk Patients for Cardiovascular Disease.
Stefania Tacconelli, Melania Dovizio, Luigia Di Francesco, Alessandra Meneguzzi, Ilaria D'Agostino, Marta L Capone

Clin Pharmacol Ther· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences.
Paola Anzellotti, Marta L Capone, Anita Jeyam, Stefania Tacconelli, Annalisa Bruno

Arthritis Rheum· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NSAIDs and cardiovascular disease: transducing human pharmacology results into clinical read-outs in the general population.
Marta L Capone, Stefania Tacconelli, Luis Garcia Rodriguez, Paola Patrignani

Pharmacol Rep· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of 8-iso-prostaglandin F2alpha in biological fluids as a measure of lipid peroxidation.
Stefania Tacconelli, Marta L Capone, Paola Patrignani

Methods Mol Biol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of traditional nonsteroidal antiinflammatory drugs and cyclooxygenase-2 inhibitors in the treatment of inflammation and pain.
Maria G Sciulli, Marta L Capone, Stefania Tacconelli, Paola Patrignani

Pharmacol Rep· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of AF3442 [N-(9-ethyl-9H-carbazol-3-yl)-2-(trifluoromethyl)benzamide], a novel inhibitor of human microsomal prostaglandin E synthase-1, on prostanoid biosynthesis in human monocytes in vitro.
Annalisa Bruno, Luigia Di Francesco, Isabella Coletta, Giorgina Mangano, Maria Alessandra Alisi, Marta L Capone

Biochem Pharmacol· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk management profile of etoricoxib: an example of personalized medicine.
Paola Patrignani, Stefania Tacconelli, Marta L Capone

Ther Clin Risk Manag· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential association between human prostacyclin receptor polymorphisms and the development of venous thrombosis and intimal hyperplasia: a clinical biomarker study.
Paola Patrignani, Concetta Di Febbo, Stefania Tacconelli, Karen Douville, Maria D Guglielmi, Marta L Capone

Pharmacogenet Genomics· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NSAIDs and cardiovascular disease.
Paola Patrignani, Marta L Capone, Stefania Tacconelli

Heart· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular effects of valdecoxib: transducing human pharmacology results into clinical read-outs.
Marta L Capone, Stefania Tacconelli, Luigia Di Francesco, Maria Petrelli, Paola Patrignani

Expert Opin Drug Saf· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human pharmacology of naproxen sodium.
Marta L Capone, Stefania Tacconelli, Maria G Sciulli, Paola Anzellotti, Luigia Di Francesco

J Pharmacol Exp Ther· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic of cyclooxygenase inhibitors in humans.
Marta L Capone, Stefania Tacconelli, Luigia Di Francesco, Andrea Sacchetti, Maria G Sciulli

Prostaglandins Other Lipid Mediat· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease.
Giulia Renda, Stefania Tacconelli, Marta L Capone, Daniele Sacchetta, Francesco Santarelli

Clin Pharmacol Ther· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
Maria G Sciulli, Giulia Renda, Marta L Capone, Stefania Tacconelli, Emanuela Ricciotti

Clin Pharmacol Ther· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced thromboxane biosynthesis in carriers of toll-like receptor 4 polymorphisms in vivo.
Paola Patrignani, Concetta Di Febbo, Stefania Tacconelli, Valeria Moretta, Giovanna Baccante, Marta L Capone

Blood· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De novo synthesis of cyclooxygenase-1 counteracts the suppression of platelet thromboxane biosynthesis by aspirin.
Virgilio Evangelista, Stefano Manarini, Angelo Di Santo, Marta L Capone, Emanuela Ricciotti

Circ Res· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacology of etoricoxib.
Marta L Capone, Stefania Tacconelli, Paola Patrignani

Expert Opin Drug Metab Toxicol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects.
Marta L Capone, Maria G Sciulli, Stefania Tacconelli, Marilena Grana, Emanuela Ricciotti

J Am Coll Cardiol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New insights into COX-2 biology and inhibition.
Paola Patrignani, Stefania Tacconelli, Maria Gina Sciulli, Marta L Capone

Brain Res Brain Res Rev· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects.
Marta L Capone, Stefania Tacconelli, Maria G Sciulli, Marilena Grana, Emanuela Ricciotti

Circulation· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of platelet activation in human essential hypertension.
Pietro Minuz, Paola Patrignani, Stefania Gaino, Francesca Seta, Marta L Capone

Hypertension· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The biochemical selectivity of novel COX-2 inhibitors in whole blood assays of COX-isozyme activity.
Stefania Tacconelli, Marta L Capone, Maria G Sciulli, Emanuela Ricciotti, Paola Patrignani

Curr Med Res Opin· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacology of etoricoxib: a novel selective COX2 inhibitor.
Paola Patrignani, Marta L Capone, Stefania Tacconelli

Expert Opin Pharmacother· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of acetaminophen on constitutive and inducible prostanoid biosynthesis in human blood cells.
Maria G Sciulli, Francesca Seta, Stefania Tacconelli, Marta L Capone, Emanuela Ricciotti

Br J Pharmacol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease.
Pietro Minuz, Paola Patrignani, Stefania Gaino, Maurizio Degan, Laura Menapace, Marta L Capone

Circulation· November 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis